Mi Bai

Nanjing Medical University

H指数:18

被引数:1,313

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting renal tubular WWP2 to restore mitochondrial OXPHOS integrity retards the AKI-to-CKD transition

靶向肾小管WWP2以恢复线粒体OXPHOS完整性延缓了AKI向CKD的转化

Molecular Therapy

IF12

2025-11-170

PRE

HNF3α Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia-Reperfusion Injury

HNF3α靶向Nckap1l并促进缺血再灌注损伤后的肾纤维化

ADVANCED SCIENCE

IF14.1

2025-03-170

OAAI

HUWE1-Mediated Degradation of MUTYH Facilitates DNA Damage and Mitochondrial Dysfunction to Promote Acute Kidney Injury

HUWE1介导的MUTYH降解通过促进DNA损伤和线粒体功能障碍来加剧急性肾损伤

ADVANCED SCIENCE

IF14.1

2025-02-080

OAAI

Slc25a21 in cisplatin-induced acute kidney injury: a new target for renal tubular epithelial protection by regulating mitochondrial metabolic homeostasis

Slc25a21在顺铂诱导的急性肾损伤中: 通过调节线粒体代谢稳态保护肾小管上皮的新靶点

CELL DEATH & DISEASE

IF9.6

2024-12-180

OAAI

Activation of LONP1 by 84-B10 alleviates aristolochic acid nephropathy via re-establishing mitochondrial and peroxisomal homeostasis

CHINESE JOURNAL OF NATURAL MEDICINES

IF4.9

2024-09-011

PRE

Meis1 Targets Protein Tyrosine Phosphatase Receptor J in Fibroblast to Retard Chronic Kidney Disease Progression

Meis1靶向成纤维细胞蛋白酪氨酸磷酸酶受体J延缓慢性肾脏病进展

ADVANCED SCIENCE

IF14.1

2024-08-201

OAAI

DY131 activates ERRγ/TFAM axis to protect against metabolic disorders and acute kidney injury

CLINICAL SCIENCE

IF7.7

2024-06-210

Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling

CELL REPORTS

IF6.9

2024-04-012

From physiology to pathology: the role of mitochondria in acute kidney injuries and chronic kidney diseases

KIDNEY DISEASES

IF3.1

2023-04-047

OAAI

Flavonoid derivative DMXAA attenuates cisplatin-induced acute kidney injury independent of STING signaling

CLINICAL SCIENCE

IF7.7

2023-03-217

LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease

EMBO MOLECULAR MEDICINE

IF8.3

2023-01-1122

OAAI

Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability

抗贫血药物FG4592通过改善血管再生和抗氧化能力来延缓AKI向CKD的转变

CLINICAL SCIENCE

IF7.7

2021-07-2232

SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation

KIDNEY DISEASES

IF3.1

2021-03-1014

OAAI

The emerging role of MEIS1 in cell proliferation and differentiation

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

IF4.7

2021-03-0130

PREAI

Mitochondrial dysfunction and the AKI-to-CKD transition

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY

IF3.4

2020-12-01131

PREAI

Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI

核受体PXR靶向AKR1B7保护AKI患者线粒体代谢和肾功能

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2020-05-1349

PREAI

BMP1 inhibitor UK383,367 attenuates renal fibrosis and inflammation in CKD

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY

IF3.4

2019-12-0117

OAAI

MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation

KIDNEY INTERNATIONAL

IF12.6

2019-06-0172

OAAI

Angiotensin II Stimulates the NLRP3 Inflammasome to Induce Podocyte Injury and Mitochondrial Dysfunction

KIDNEY DISEASES

IF3.1

2018-05-2262

MicroRNA-30e targets BNIP3L to protect against aldosterone-induced podocyte apoptosis and mitochondrial dysfunction

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY

IF3.4

2017-04-0119

OAAI

Mi Bai

个人简介

教育背景

工作经历

荣誉奖项

研究方向